Join Now

Category Archives: BioUtah News

Soft Cell Labs announces new Urinary Tract Infection Test

By Natalie Themm | Published August 8, 2022

Soft Cell Labs announces new Urinary Tract Infection Test

| Tagged | Leave a comment

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

By Natalie Themm | Published August 4, 2022

ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers

| Tagged , | Leave a comment

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

By Natalie Themm | Published August 4, 2022

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

| Tagged | Leave a comment

3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business

By Natalie Themm | Published August 4, 2022

New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology, manufacturing, global capabilities, and iconic brands

| Tagged | Leave a comment

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

By Natalie Themm | Published August 3, 2022

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

Also posted in Policy News | | Leave a comment

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022

By Natalie Themm | Published July 28, 2022

UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections.

| Tagged | Leave a comment

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer

By Natalie Themm | Published July 28, 2022

Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of brain cancer. 

| Tagged | Leave a comment

Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women

By Natalie Themm | Published July 28, 2022

ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned the company recognition as one of Forbes magazine’s Best Employers for Women 2022. The Forbes ranking, first published online on Tuesday, July 26, places ARUP 236th on a list of 300 companies nationwide. Winners were chosen based […]

| Tagged | Leave a comment

Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers

By Natalie Themm | Published July 28, 2022

Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry.

| Tagged | Leave a comment

Clene’s ALS Drug Increases Survival by 70% in Mid-stage Study

By Natalie Themm | Published July 28, 2022

Shares of Clene, Inc. surged Thursday after the company released “golden” data from an interim analysis of a Phase II study.

| Tagged | Leave a comment

Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

By Natalie Themm | Published July 28, 2022

Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions

| Tagged | Leave a comment

Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC

By Natalie Themm | Published July 27, 2022

Co-Diagnostics announced that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company’s customer and distributor update today at AACC.

| Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members